Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Accepted on 14 Aug 2025

Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood samples in patients with pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ruoxiang Wang
Kenneth Park
Srinivas Gaddam
Quin Liu
Rabindra Watson
Adrian Lim
Yan Ou
Yi Zhang
Mouad Edderkaoui
Michael Lewis

Frontiers in Oncology

doi 10.3389/fonc.2025.1611872

Case Report

Accepted on 13 Aug 2025

Concurrent Two Adenomatoid Tumors of Liver: A Case Report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lei Bi

Frontiers in Oncology

doi 10.3389/fonc.2025.1640018

Original Research

Published on 13 Aug 2025

Liposomal irinotecan with fluorouracil and leucovorin as salvage treatment for advanced biliary tract cancer refractory to gemcitabine and cisplatin

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hyunho Kim
Kabsoo Shin
Hyung Soon Park
Tae Ho Hong
Younghoon Kim
Sung Hak Lee
In-Ho Kim
MyungAh Lee
Se Jun Park

Frontiers in Oncology

doi 10.3389/fonc.2025.1638606

313 views

Original Research

Accepted on 12 Aug 2025

ISG15 mRNA Transcript Level in Circulating Leucocytes Prognostic of Overall Survival in Hepatocellular Carcinoma Patients and Correlated with Quality of Life Disturbances involved in Anorexiacachexia

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Leung Li
Nelson L S Tang
Frankie Mo
Jane Koh
Edwin P Hui
Brigette Ma
Stephen Lam CHAN
Kit F Lee
Simon CH Yu
Winnie Yeo

Frontiers in Oncology

doi 10.3389/fonc.2025.1589053

132 views

Original Research

Accepted on 11 Aug 2025

Efficacy and Liver Function Preservation with Donafenib Combined with Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma: An ALBI grade Analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jinpeng Li
Yuanming Li
Jiasheng Du
Lujun Zhao
Jingtao Zhong

Frontiers in Oncology

doi 10.3389/fonc.2025.1612477

101 views

Original Research

Published on 11 Aug 2025

Transcriptomic analysis on pancreatic adenocarcinoma patients uncovers KRAS-mediated PPAR pathway alteration

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Giuseppe Defazio
Federico Scolari
Sara Fancelli
Simone Polvani
Daniele Lavacchi
Lucia Picariello
Alessandro Tubita
Michaela Luconi
Lorenzo Antonuzzo
Andrea Galli

Frontiers in Oncology

doi 10.3389/fonc.2025.1613773

401 views

Original Research

Accepted on 08 Aug 2025

Comparison of Albumin-Bilirubin (ALBI), Platelet-Albumin-Bilirubin (PALBI), and Child-Pugh (CP) scores to predict overall survival in patients with stage C hepatocellular carcinoma with liver cirrhosis treated with c-TACE

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fei Wu
Zhihong Zhang
Shanshan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1613697

130 views

Case Report

Published on 06 Aug 2025

Case Report: A rare case of hepatic undifferentiated pleomorphic sarcoma: diagnostic dilemmas and multidisciplinary management strategies

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yu Yang
Yiwei Hou
Li Yi
Mingzhi Jiang
Lihua Tang
Mingzheng Hu
Rongchun Xing

Frontiers in Oncology

doi 10.3389/fonc.2025.1572348

377 views

Original Research

Published on 04 Aug 2025

Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ankur Chakravarthy
Elisa Pasini
Xun Zhao
Jeffrey To
Shu Yi (Roxana) Shen
Sandra Fischer
Anand Ghanekar
Arndt Vogel
Robert C. Grant
Jennifer Knox

Frontiers in Oncology

doi 10.3389/fonc.2025.1537087

491 views

Case Report

Published on 04 Aug 2025

Case Report: Epstein-Barr virus negative lymphoepithelioma-like cholangiocarcinoma: a rare tumor that deserves further exploration. Report of a case with distinct genomic and clinical features

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Salvatore Corallo
Chiara Milani
Alessandro Vanoli
Anna Gallotti
Anna Pagani
Francesco Serra
Marcello Maestri
Valentina Ravetta
Angioletta Lasagna
Paolo Pedrazzoli

Frontiers in Oncology

doi 10.3389/fonc.2025.1620328

600 views

Original Research

Published on 01 Aug 2025

Pre-operative T-stage discrimination in gallbladder cancer using machine learning and DeepSeek-R1

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Joongwon Chae
Zhenyu Wang
Duanpo Wu
Lian Zhang
Alexander Tuzikov
Magrupov Talat Madiyevich
Min Xu
Dongmei Yu
Peiwu Qin

Frontiers in Oncology

doi 10.3389/fonc.2025.1613462

644 views

Case Report

Published on 31 Jul 2025

Mixed adenoneuroendocrine carcinoma of the gallbladder: a case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fan-Hua Kong
Guo-Dong Xu
Chang-Qing Liu
Hao Ma
Yun-Xuan Zou
Xiu-Feng Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1584744

527 views

Review

Published on 31 Jul 2025

Applications of 3D models in cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Agata Montagner
Laura Lemberger-Viehmann
Nadine Reitberger
Milena Schmidt
Julia Scheruebl
Eric Pion
Benedikt J. Wagner
Christian Pilarsky
Robert Grützmann
Thiha Aung

Frontiers in Oncology

doi 10.3389/fonc.2025.1598552

809 views

Systematic Review

Accepted on 30 Jul 2025

Diagnosis methods for Pancreatic cancer with the technique of deep learning: a review and a meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yuanbo Bi
Dongrui Li
Ruochen Pang
Chengxv Du
Da Li
Xiaoyv Zhao
Lv Haitao

Frontiers in Oncology

doi 10.3389/fonc.2025.1597969

331 views

Systematic Review

Published on 30 Jul 2025

Impact of lymph node dissection on the prognosis of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jun Yu
Fan Zhou
Xing-Guo Tan
Jun Guo
Wei Feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1590019

520 views

Methods

Published on 30 Jul 2025

Postoperative adjuvant hepatic arterial infusion chemotherapy with gemcitabine-cisplatin sequential capecitabine combined with PDL1 inhibitors in resected high-risk intrahepatic cholangiocarcinom: study protocol for a prospective, multicenter, single-arm, phase 2 trial (HgcCP trial)

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ying Yang
Qing-Yun Xie
Tao Lv
Jiayin Yang
Hai-Peng Yu
Xin Zheng
Hui Zhang
Chang Liu
Hong Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1584007

529 views